Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

Constantinos Petsoglou; Kamaljit S Balaggan; John K G Dart; Catey Bunce; Wen Xing; Robin R Ali; Stephen J Tuft

doi:10.1136/bjophthalmol-2012-302137

Article info

Clinical science

Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

Authors

Constantinos Petsoglou Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Kamaljit S Balaggan Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
John K G Dart Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles
Catey Bunce Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Wen Xing Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Robin R Ali Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Stephen J Tuft Department of Cornea, Moorfields Eye Hospital NHS Foundation Trust, London, UK UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles

Correspondence to Dr Stephen J Tuft, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK; s.tuft{at}ucl.ac.uk

View Full Text

Citation

Petsoglou C, Balaggan KS, Dart JKG, et al

Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

British Journal of Ophthalmology 2013;97:28-32.

Publication history

Received May 29, 2012
Revised September 17, 2012
Accepted September 21, 2012
First published October 20, 2012.

Online issue publication

September 26, 2016

Article Versions

Previous version (22 March 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password